Integrated pharmaceutical manufacturer and CDMO delivering APIs, advanced chemical intermediates and finished-dosage forms for cardiovascular, anti‑infective, psychotropic and oncology therapies. Provides end-to-end development and manufacturing with global regulatory approvals and technology‑driven, cost‑efficient R&D to advance partner molecules to market.